STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 1st, 2018 • OvaScience, Inc. • Pharmaceutical preparations • Delaware
This Stock Purchase Agreement (this “Agreement”) is made and entered into as of the 1st day of November, 2018 (the “Effective Date”), by and among OvaScience, Inc., a Delaware corporation (the “OvaScience”), the purchasers set forth on Schedule I attached to this Agreement (each a “Purchaser” and collectively, the “Purchasers”) and Millendo Therapeutics Inc. (the “Company” and together with OvaScience, the “Merger Parties”). Each Purchaser, the Company and OvaScience shall be referred to herein as a “Party” and, collectively, as the “Parties”.
ATTEROCOR, INC. JULIA C. OWENS EMPLOYMENT AGREEMENTEmployment Agreement • November 1st, 2018 • OvaScience, Inc. • Pharmaceutical preparations • Michigan
This Employment Agreement (the “Agreement”) is entered into as of July 25, 2012 (the “Effective Date”) by and between Atterocor, Inc. (the “Company”), and Julia C. Owens (“Executive”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 1st, 2018 • OvaScience, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made as of the 1st day of November, 2018, by and among, OvaScience, Inc. (the “Company”) and the persons listed on the attached Schedule A who are signatories to this Agreement (collectively, the “Investors”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.
ASSIGNMENT AGREEMENTAssignment Agreement • November 1st, 2018 • OvaScience, Inc. • Pharmaceutical preparations • Quebec
BETWEEN: ALIZÉ PHARMA SAS, a simplified joint stock company (société par actions simplifiée) constituted pursuant to the Laws of France, having its head office at 13, chemin de la Chonchance, 69 110 Ste-Foy-lès-Lyon, France, herein acting and represented by Thierry Abribat, its President, duly authorized, as he so declares;
